# More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

> **NCT01445691** · PHASE2 · WITHDRAWN · sponsor: **Constantinos Hadjipanayis**

## Conditions studied

- Benign Neoplasms, Brain
- Brain Cancer
- Brain Neoplasms, Benign
- Brain Neoplasms, Malignant
- Brain Tumor, Primary
- Brain Tumor, Recurrent
- Brain Tumors
- Intracranial Neoplasms
- Neoplasms, Brain
- Neoplasms, Intracranial
- Primary Brain Neoplasms
- Primary Malignant Brain Neoplasms
- Primary Malignant Brain Tumors
- Gliomas
- Glioblastoma

## Interventions

- **DRUG:** 5-ALA (Gliolan)

## Key facts

- **NCT ID:** NCT01445691
- **Lead sponsor:** Constantinos Hadjipanayis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-11
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-05-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01445691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01445691, "More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01445691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*